Hematology and oncology are closely intertwined and rapidly evolving fields. More physician scientists performing laboratory-based research are rapidly bringing research in hematology and oncology from bench to bedside. Journal of Hematology & Oncology aims to meet the demand for a journal dedicated to ...
亚盛医药首席医学官翟一帆博士表示:"耐立克®是具有"best-in-class"潜力的原创1类新药,其临床开发是亚盛医药全球创新战略的践行。此次耐立克®的I/II期临床进展荣登Journal of Hematology&Oncology,既体现了该品种在全球耐药CML领域的治疗潜力,更代表公司的全球创新战略再斩佳绩。我们迫切地期待耐立克®能以中国为起...
Critical Reviews in Oncology/Hematology 11.0CiteScore 5.5Impact Factor Order journal All issues 2025 — Volumes 205-206 Volume 206 In progress(February 2025) Volume 205 January 2025 2024 — Volumes 193-204 2023 — Volumes 181-192 2022 — Volumes 169-180 ...
Impact Factor 1.433 Impact Factor 1.126 The Breast Journal 2013 JCR Ranking: 53/78 Obstetrics & Gynecology Category Sample Online Issue Thoracic Cancer 2013 JCR Ranking: 47/53 Respiratory System Category Sample Online Issue Impact Factor 1.058 Asia-Pacific Journal of Clinical Oncology 2013 JCR Ranking...
Journal Impact Factor 1 BLOOD 165,117 17.543 2 CIRCULATION RESEARCH 51,539 14.467 3 Journal of Hematology & Oncology 6,732 11.059 4 Lancet Haematology 2,446 10.406 5 LEUKEMIA 25,819 8.665 6 Blood Cancer Journal 2,800 8.023 7 HAEMATOLOGICA 17,314 7.116 8 AMERICAN JOURNAL OF HEMATOLOGY 10,629...
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared ...
此次耐立克®的I/II期临床进展荣登Journal of Hematology&Oncology,既体现了该品种在全球耐药CML领域的治疗潜力,更代表公司的全球创新战略再斩佳绩。我们迫切地期待耐立克®能以中国为起点,为全球耐药CML患者带去一种疗效确切、安全性更佳的治疗方案。未来,我们将继续坚守‘解决中国乃至全球患者尚未满足的临床需求'的...
Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The ...
Annals of Hematology & Oncology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of Hematology & Oncology.
学科:ONCOLOGYSCIEQ113 / 322 96.12% 名词解释: 汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。